FDA Inspection 808880 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 1640962

The FDA completed an inspection of Biomat USA, Inc. on Nov 30, 2012 in Midwest City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 30, 2012
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Midwest City, OK (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.